The Patent Finder

Phenome Sciences Inc.

Also on record
Records under this name other than patents Phenome Sciences Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Phenome Sciences Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,610,270In vivo determination of metabolic function for use in therapy management
Lapsed on the fee record
Ended Aug 26, 2011 · USPTO record
Lapsed on the fee recordEnded Aug 26, 2011USPTO record
US 6,284,219In vivo determination of metabolic function for use in therapy management
Formerly held
Lapsed on the fee record
Ended Sep 4, 2009 · USPTO record
Lapsed on the fee recordEnded Sep 4, 2009USPTO record
US 5,095,027Method for treating reperfusion injury employing L-2-oxothiazolidine-4-carboxylic acid
Formerly held
Term ended
Term ended no later than Mar 10, 2012 · Low confidence
Term endedTerm ended no later than Mar 10, 2012Low confidence
US 5,208,249Method for stimulating intracellular synthesis of glutathione using esters of L-2-oxothiazolidine-4-carboxylate
Formerly held
Term ended
Term ended no later than May 4, 2013 · Low confidence
Term endedTerm ended no later than May 4, 2013Low confidence
US 5,306,724Method for preventing and treating atherosclerosis
Formerly held
Term ended
Term ended no later than Apr 26, 2014 · Low confidence
Term endedTerm ended no later than Apr 26, 2014Low confidence
US 5,430,045Method of reducing or preventing bone marrow hypoplasia
Formerly held
Term ended
Term ended no later than Jul 4, 2015 · Low confidence
Term endedTerm ended no later than Jul 4, 2015Low confidence
US 5,447,712Method of reducing cyclophosphamide induced hemorrhagic cystitis
Formerly held
Term ended
Term ended no later than Sep 5, 2015 · Low confidence
Term endedTerm ended no later than Sep 5, 2015Low confidence
US 5,780,489Method for treating amyotrophic lateral sclerosis
Formerly held
Term ended
Term ended no later than Jul 14, 2018 · Low confidence
Term endedTerm ended no later than Jul 14, 2018Low confidence
US 5,824,693Method for treatment for pulmonary disease
Formerly held
Term ended
Term ended no later than Oct 20, 2018 · Low confidence
Term endedTerm ended no later than Oct 20, 2018Low confidence
US 5,869,679Methods for preparing l-2-oxothiazolidine-4-carboxylate and its carboxylic acid
Formerly held
Term ended
Term ended no later than Feb 9, 2019 · Low confidence
Term endedTerm ended no later than Feb 9, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited